Nifty

:

23850.90

Sensex

:

78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Login

Nifty
Sensex

:
:

23850.90
78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Concord Biotech Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 543960 | NSE: CONCORDBIO

Watchlist

NSE BSE

1683.70

05-Jul-2024

Open
High
Low
Previous Close

1715.05
1715.05
1665.10
1716.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

120079
2032.36
2664.00
1133.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

18,964.83
60.55
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

18,924.03
0.48%
11.97

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.60
-
12.57

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.58
-
9.55

PAT CAGR (%)

10 Years
5 Years
3 Years

15.80
-
20.77

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 215.80 194.83 10.76% 318.97 272.58 17.02% 240.80 240.68 0.05% 262.35 158.90 65.10%
Expenses 134.52 122.67 9.66% 184.68 143.52 28.68% 134.87 129.00 4.55% 143.16 120.98 18.33%
EBITDA 81.28 72.15 12.65% 134.29 129.06 4.05% 105.93 111.68 -5.15% 119.19 37.92 214.32%
EBIDTM 37.66% 37.03% 42.10% 47.35% 43.99% 46.40% 45.43% 23.86%
Other Income 10.31 6.65 55.04% 10.81 12.20 -11.39% 8.19 9.25 -11.46% 8.13 6.03 34.83%
Interest 0.24 0.75 -68.00% 0.46 1.45 -68.28% 0.50 0.91 -45.05% 0.84 1.11 -24.32%
Depreciation 13.18 13.04 1.07% 13.72 14.18 -3.24% 13.54 13.77 -1.67% 13.29 12.51 6.24%
PBT 78.17 65.01 20.24% 130.92 125.62 4.22% 100.09 106.25 -5.80% 113.18 30.33 273.16%
Tax 19.93 16.54 20.50% 33.70 32.12 4.92% 25.53 27.17 -6.04% 28.69 7.88 264.09%
PAT 58.24 48.47 20.16% 97.22 93.51 3.97% 74.55 79.08 -5.73% 84.49 22.45 276.35%
PATM 26.99% 24.88% 30.48% 34.30% 30.96% 32.85% 32.21% 14.13%
EPS 5.57 4.63 20.30% 9.29 8.94 3.91% 7.13 7.56 -5.69% 8.08 2.15 275.81%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 215.80 194.83 10.76% 318.97 272.58 17.02% 240.80 240.68 0.05% 262.35 158.90 65.10%
Expenses 134.52 122.67 9.66% 184.68 143.52 28.68% 134.87 129.00 4.55% 143.16 120.98 18.33%
EBITDA 81.28 72.15 12.65% 134.29 129.06 4.05% 105.93 111.68 -5.15% 119.19 37.92 214.32%
EBIDTM 37.66% 37.03% 42.10% 47.35% 43.99% 46.40% 45.43% 23.86%
Other Income 10.31 6.65 55.04% 10.81 12.20 -11.39% 8.19 9.25 -11.46% 8.13 6.03 34.83%
Interest 0.24 0.75 -68.00% 0.46 1.45 -68.28% 0.50 0.91 -45.05% 0.84 1.11 -24.32%
Depreciation 13.18 13.04 1.07% 13.72 14.18 -3.24% 13.54 13.77 -1.67% 13.29 12.51 6.24%
PBT 78.17 65.01 20.24% 130.92 125.62 4.22% 100.09 106.25 -5.80% 113.18 30.33 273.16%
Tax 19.93 16.54 20.50% 33.70 32.12 4.92% 25.53 27.17 -6.04% 28.69 7.88 264.09%
PAT 58.24 48.47 20.16% 97.22 93.51 3.97% 74.55 79.08 -5.73% 84.49 22.45 276.35%
PATM 26.99% 24.88% 30.48% 34.30% 30.96% 32.85% 32.21% 14.13%
EPS 5.70 5.21 9.40% 9.08 8.75 3.77% 7.41 7.40 0.14% 7.74 2.10 268.57%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,037.92 1,016.94 853.17 712.93 616.94 276.17 238.53 204.82 164.91 135.60 108.59 Net Sales Growth 19.72% 19.20% 19.67% 15.56% 123.39% 15.78% 16.46% 24.20% 21.62% 24.87% Cost Of Goods Sold 237.10 229.20 180.21 164.01 111.56 63.26 54.22 48.88 34.30 25.07 16.78 Gross Profit 800.82 787.74 672.96 548.92 505.37 212.91 184.31 155.93 130.61 110.53 91.81 GP Margin 77.16% 77.46% 78.88% 76.99% 81.92% 77.09% 77.27% 76.13% 79.20% 81.51% 84.55% Total Expenditure 597.23 584.75 504.59 439.01 289.01 140.63 127.67 119.26 88.75 69.85 49.51 Power & Fuel Cost - 104.97 97.65 71.64 39.86 26.89 28.90 29.45 25.71 21.27 15.15 % Of Sales - 10.32% 11.45% 10.05% 6.46% 9.74% 12.12% 14.38% 15.59% 15.69% 13.95% Employee Cost - 123.05 110.28 95.69 69.47 22.87 19.78 15.57 13.44 10.88 8.27 % Of Sales - 12.10% 12.93% 13.42% 11.26% 8.28% 8.29% 7.60% 8.15% 8.02% 7.62% Manufacturing Exp. - 31.23 38.44 32.45 21.97 12.42 12.32 12.35 8.45 7.00 4.99 % Of Sales - 3.07% 4.51% 4.55% 3.56% 4.50% 5.16% 6.03% 5.12% 5.16% 4.60% General & Admin Exp. - 54.73 45.72 31.09 22.52 8.72 6.53 6.42 3.54 2.59 1.81 % Of Sales - 5.38% 5.36% 4.36% 3.65% 3.16% 2.74% 3.13% 2.15% 1.91% 1.67% Selling & Distn. Exp. - 33.11 23.70 21.44 13.36 4.80 4.40 3.68 2.00 1.44 1.73 % Of Sales - 3.26% 2.78% 3.01% 2.17% 1.74% 1.84% 1.80% 1.21% 1.06% 1.59% Miscellaneous Exp. - 8.46 8.59 22.69 10.26 1.67 1.52 2.90 1.31 1.59 1.73 % Of Sales - 0.83% 1.01% 3.18% 1.66% 0.60% 0.64% 1.42% 0.79% 1.17% 0.71% EBITDA 440.69 432.19 348.58 273.92 327.93 135.54 110.86 85.56 76.16 65.75 59.08 EBITDA Margin 42.46% 42.50% 40.86% 38.42% 53.15% 49.08% 46.48% 41.77% 46.18% 48.49% 54.41% Other Income 37.44 33.78 35.31 23.42 13.81 4.58 5.51 2.83 5.31 2.58 3.81 Interest 2.04 3.18 9.80 6.13 1.05 0.32 0.82 0.70 0.30 0.41 0.35 Depreciation 53.73 53.59 54.03 50.05 27.52 10.46 9.67 11.43 10.14 8.97 7.26 PBT 422.36 409.19 320.05 241.16 313.17 129.34 105.88 76.25 71.04 58.95 55.28 Tax 107.85 104.46 81.93 62.59 77.83 42.09 35.63 21.83 21.65 17.17 16.00 Tax Rate 25.54% 25.53% 25.60% 25.95% 24.85% 32.54% 33.65% 28.63% 30.48% 29.13% 28.94% PAT 314.50 304.73 238.13 178.57 235.33 87.25 70.25 54.41 49.39 41.78 39.28 PAT before Minority Interest 314.50 304.73 238.13 178.57 235.33 87.25 70.25 54.41 49.39 41.78 39.28 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 30.30% 29.97% 27.91% 25.05% 38.14% 31.59% 29.45% 26.56% 29.95% 30.81% 36.17% PAT Growth 29.15% 27.97% 33.35% -24.12% 169.72% 24.20% 29.11% 10.16% 18.21% 6.36% EPS 30.07 29.13 22.77 17.07 22.50 8.34 6.72 5.20 4.72 3.99 3.76

Description TTM Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 1,037.92 1,016.94 853.17 712.93 616.94 Net Sales Growth 19.72% 19.20% 19.67% 15.56% Cost Of Goods Sold 237.10 229.20 180.21 164.01 111.56 Gross Profit 800.82 787.74 672.96 548.92 505.38 GP Margin 77.16% 77.46% 78.88% 76.99% 81.92% Total Expenditure 597.23 584.75 504.59 439.01 289.01 Power & Fuel Cost - 104.97 97.65 71.64 39.86 % Of Sales - 10.32% 11.45% 10.05% 6.46% Employee Cost - 123.05 110.28 95.69 69.47 % Of Sales - 12.10% 12.93% 13.42% 11.26% Manufacturing Exp. - 31.23 38.44 32.48 21.97 % Of Sales - 3.07% 4.51% 4.56% 3.56% General & Admin Exp. - 54.73 45.72 31.09 22.52 % Of Sales - 5.38% 5.36% 4.36% 3.65% Selling & Distn. Exp. - 33.11 23.70 21.44 13.36 % Of Sales - 3.26% 2.78% 3.01% 2.17% Miscellaneous Exp. - 8.46 8.59 22.66 10.26 % Of Sales - 0.83% 1.01% 3.18% 1.66% EBITDA 440.69 432.19 348.58 273.92 327.93 EBITDA Margin 42.46% 42.50% 40.86% 38.42% 53.15% Other Income 37.44 33.78 35.31 23.42 13.81 Interest 2.04 3.18 9.80 6.13 1.05 Depreciation 53.73 53.59 54.03 50.05 27.52 PBT 422.36 409.19 320.05 241.16 313.17 Tax 107.85 104.46 81.93 62.59 77.83 Tax Rate 25.54% 25.53% 25.60% 25.95% 24.85% PAT 314.50 308.10 240.09 174.93 235.34 PAT before Minority Interest 314.50 308.10 240.09 174.93 235.34 Minority Interest 0.00 0.00 0.00 0.00 0.00 PAT Margin 30.30% 30.30% 28.14% 24.54% 38.15% PAT Growth 29.15% 28.33% 37.25% -25.67% EPS 30.07 29.46 22.95 16.72 22.50

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Shareholder's Funds 1,525.25 1,291.98 1,107.16 999.67 226.47 185.52 146.30 111.20 77.28 64.87 Share Capital 10.46 10.46 9.51 9.51 9.21 4.60 4.60 4.60 2.30 2.53 Total Reserves 1,514.79 1,281.52 1,097.65 990.16 217.26 180.92 141.69 106.60 74.98 62.34 Non-Current Liabilities 31.91 32.13 54.40 77.43 10.53 9.03 7.94 7.97 5.90 10.01 Secured Loans 0.00 6.24 31.25 56.25 0.00 0.00 0.00 0.00 2.27 7.23 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.96 2.30 1.87 2.10 0.27 0.28 0.55 0.78 0.00 0.00 Current Liabilities 142.16 190.53 340.97 235.93 37.96 27.55 24.26 21.01 16.30 16.27 Trade Payables 94.44 93.80 83.11 46.40 15.38 9.03 6.95 5.22 8.35 4.10 Other Current Liabilities 38.32 60.26 62.70 53.58 3.93 2.28 3.58 6.45 1.54 1.22 Short Term Borrowings 0.00 0.00 4.34 5.10 4.97 3.62 6.59 3.86 0.00 0.00 Short Term Provisions 9.40 36.47 190.82 130.85 13.68 12.62 7.15 5.47 6.41 10.95 Total Liabilities 1,699.32 1,514.64 1,502.53 1,313.03 274.96 222.10 178.50 140.18 99.48 91.15 Net Block 575.32 592.98 572.98 546.22 98.73 81.62 69.48 63.94 40.42 32.99 Gross Block 828.31 792.80 718.85 644.29 161.05 132.77 110.61 96.21 65.56 52.98 Accumulated Depreciation 253.00 199.81 145.87 98.08 62.31 51.15 41.14 32.28 25.14 19.99 Non Current Assets 803.08 786.95 869.87 705.89 113.02 88.35 87.86 73.36 52.46 39.43 Capital Work in Progress 211.48 172.70 74.16 17.95 8.02 3.97 14.42 7.00 12.04 6.44 Non Current Investment 0.67 0.79 0.92 0.67 0.56 0.56 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 12.81 11.61 220.99 140.61 5.72 2.00 3.77 2.41 0.00 0.00 Other Non Current Assets 2.81 8.87 0.82 0.45 0.00 0.21 0.19 0.00 0.00 0.00 Current Assets 896.23 727.70 632.67 607.15 161.94 133.75 90.64 66.81 47.03 51.72 Current Investments 243.70 136.93 73.47 140.99 0.00 2.00 2.02 0.00 3.01 12.03 Inventories 207.95 212.31 195.12 153.61 39.41 34.36 23.66 18.75 14.04 14.99 Sundry Debtors 349.61 273.76 232.17 177.52 100.35 85.43 54.83 30.17 23.82 10.91 Cash & Bank 47.02 43.45 88.93 60.82 2.67 1.53 1.04 12.22 0.61 0.23 Other Current Assets 47.94 45.57 32.53 40.37 19.50 10.42 9.09 5.67 5.54 13.55 Short Term Loans & Adv. 21.12 15.68 10.44 33.85 10.58 2.76 2.83 2.07 5.34 13.41 Net Current Assets 754.08 537.17 291.70 371.22 123.98 106.20 66.38 45.81 30.73 35.45 Total Assets 1,699.31 1,514.65 1,502.54 1,313.04 274.96 222.10 178.50 140.17 99.49 91.15

Description Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 1,526.65 1,290.00 1,103.22 999.37 Share Capital 10.46 10.46 9.51 9.51 Total Reserves 1,516.18 1,279.54 1,093.71 989.86 Non-Current Liabilities 31.91 32.13 54.40 77.43 Secured Loans 0.00 6.24 31.25 56.25 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 1.96 2.30 1.87 2.10 Current Liabilities 142.16 191.84 344.24 235.93 Trade Payables 94.44 93.80 83.11 46.40 Other Current Liabilities 38.32 61.57 65.98 53.58 Short Term Borrowings 0.00 0.00 4.34 5.10 Short Term Provisions 9.40 36.47 190.82 130.85 Total Liabilities 1,700.72 1,513.97 1,501.86 1,312.73 Net Block 575.32 592.98 572.98 546.22 Gross Block 828.31 792.80 718.85 645.33 Accumulated Depreciation 253.00 199.81 145.87 99.11 Non Current Assets 804.48 786.28 869.20 705.59 Capital Work in Progress 211.48 172.70 74.16 17.95 Non Current Investment 2.06 0.12 0.26 0.37 Long Term Loans & Adv. 12.81 11.61 220.99 140.61 Other Non Current Assets 2.81 8.87 0.82 0.45 Current Assets 896.23 727.70 632.67 607.15 Current Investments 243.70 136.93 73.47 140.99 Inventories 207.95 212.31 195.12 153.61 Sundry Debtors 349.61 273.76 232.17 177.52 Cash & Bank 47.02 43.45 88.93 60.82 Other Current Assets 47.94 45.57 32.53 40.37 Short Term Loans & Adv. 21.12 15.68 10.44 33.85 Net Current Assets 754.08 535.86 288.42 371.22 Total Assets 1,700.71 1,513.98 1,501.87 1,312.74

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Cash From Operating Activity 265.47 246.00 207.47 166.81 39.81 21.53 16.14 36.04 34.70 18.96 PBT 409.19 320.05 241.16 313.17 76.25 71.04 58.95 55.28 55.92 14.21 Adjustment 40.80 48.51 49.16 17.59 15.07 8.58 8.18 7.52 5.26 5.08 Changes in Working Capital -81.18 -52.29 -22.06 -88.77 -24.01 -41.68 -33.34 -11.66 -9.66 3.93 Cash after chg. in Working capital 368.82 316.28 268.26 241.99 67.30 37.94 33.79 51.14 51.53 23.22 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -103.35 -70.28 -60.78 -75.18 -27.49 -16.41 -17.64 -15.10 -16.82 -4.39 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 Cash From Investing Activity -154.61 -157.95 -111.79 -195.20 -31.41 -10.85 -21.79 -22.40 -8.71 -20.05 Net Fixed Assets -74.29 -172.49 -130.77 -493.17 -32.33 -11.71 -21.82 -25.61 -18.18 -8.21 Net Investments -106.65 -63.33 67.27 -141.10 2.00 -0.54 -2.02 3.01 9.02 -12.03 Others 26.33 77.87 -48.29 439.07 -1.08 1.40 2.05 0.20 0.45 0.19 Cash from Financing Activity -99.21 -85.22 -100.16 31.12 -9.32 -9.82 -3.83 -1.98 -25.61 0.14 Net Cash Inflow / Outflow 11.64 2.83 -4.48 2.74 -0.91 0.85 -9.48 11.66 0.38 -0.95 Opening Cash & Equivalents 3.50 0.67 5.14 2.41 3.52 2.66 12.14 0.57 0.23 1.18 Closing Cash & Equivalent 15.14 3.50 0.67 5.14 2.60 3.52 2.66 12.22 0.61 0.23

Description Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 265.47 246.00 207.47 166.82 PBT 412.56 322.01 237.52 312.72 Adjustment 37.43 46.55 52.80 18.04 Changes in Working Capital -81.18 -52.29 -22.05 -88.76 Cash after chg. in Working capital 368.82 316.28 268.26 241.99 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -103.35 -70.28 -60.78 -75.18 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -154.61 -157.95 -111.79 -195.21 Net Fixed Assets -74.29 -172.49 -130.77 Net Investments -106.65 -63.33 67.27 Others 26.33 77.87 -48.29 Cash from Financing Activity -99.21 -85.22 -100.16 31.12 Net Cash Inflow / Outflow 11.64 2.83 -4.48 2.74 Opening Cash & Equivalents 3.50 0.67 5.14 2.41 Closing Cash & Equivalent 15.14 3.50 0.67 5.14

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Book Value (Rs.) 145.80 123.50 105.83 95.56 246.02 403.07 317.85 241.60 335.83 256.06 ROA 18.96% 15.78% 12.68% 20.89% 21.89% 24.66% 26.22% 32.78% 38.53% 11.59% ROE 21.63% 19.85% 16.95% 26.60% 26.42% 29.77% 32.45% 41.68% 51.67% 16.10% ROCE 28.89% 26.48% 21.94% 33.00% 36.59% 41.71% 44.18% 56.95% 74.38% 22.42% Fixed Asset Turnover 1.25 1.13 1.05 1.29 1.44 1.42 1.35 1.39 1.79 1.06 Receivable days 111.87 108.22 104.87 106.80 160.03 148.42 111.49 87.54 59.62 67.04 Inventory Days 75.42 87.15 89.27 78.34 63.55 61.40 55.63 53.17 49.83 113.67 Payable days 149.88 179.16 144.10 192.42 36.90 30.92 29.60 45.56 48.65 29.49 Cash Conversion Cycle 37.41 16.22 50.04 -7.28 186.68 178.90 137.51 95.15 60.81 151.22 Total Debt/Equity 0.00 0.02 0.05 0.09 0.02 0.02 0.05 0.04 0.03 0.11 Interest Cover 129.52 33.65 40.31 300.20 109.58 238.74 144.64 156.79 119.05 19.33

Description Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 145.93 123.31 105.45 95.52 ROA 19.17% 15.92% 12.43% 20.89% ROE 21.88% 20.06% 16.64% 26.60% ROCE 29.13% 26.70% 21.66% 33.01% Fixed Asset Turnover 1.25 1.13 1.05 1.29 Receivable days 111.87 108.22 104.87 106.80 Inventory Days 75.42 87.15 89.27 78.34 Payable days 149.88 179.16 144.10 192.42 Cash Conversion Cycle 37.41 16.22 50.04 -7.28 Total Debt/Equity 0.00 0.02 0.05 0.09 Interest Cover 130.57 33.85 39.72 300.11

Top Investors:

rekha rakesh jhunjhunwala

rekha rakesh jhunjhunwala

rekha rakesh jhunjhunwala

government pension fund global

1575773 ontario inc

max life insurance company limited a/c reversionary bonus participating - equity

tata aia life insurance co ltd unit linked multi cap fund

ravindra raichand dharamshi

chanakya corporate services private limited

Annual Reports:

News Update:

Concord Biotech - Quarterly Results
9th Aug 2024, 13:41 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback